RecruitingNot ApplicableNCT07480668

Aromatherapy for Mental Health Promotion in IVF Patients

Aromatherapy for Mental Health Promotion in In Vitro Fertilization Patients: a Randomized Clinical Trial


Sponsor

Federal University of Minas Gerais

Enrollment

120 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment. 120 participants will be randomized into three groups (Intervention, Placebo, and Control). The intervention involves the inhalation of true lavender essential oil (Lavandula angustifolia) for four weeks.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • Female gender, age over 18 years.
  • Diagnosis of infertility with indication for In Vitro Fertilization (IVF).
  • Patients on the waiting list at HC-UFMG.
  • Agreement not to practice other mind-body or herbal complementary therapies during the study.
  • DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression.
  • No aversion to inhaling essential oil or synthetic lavender essence.

Exclusion Criteria5

  • Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation.
  • Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior to or during the study.
  • Known allergy to lavender products.
  • Pregnancy during the study period.
  • Use of essential oils in the last 90 days.

Interventions

COMBINATION_PRODUCTLavender essential oil Inhalation

The inhalation of lavender essential oil will be performed twice a day, preferably upon waking and before nighttime sleep. Participants will be instructed to settle into a quiet environment, lying down or sitting, to consciously perform the inhalation. The procedure consists of opening the inhaler, positioning it approximately 1cm from the nostrils, and beginning the inhalation through habitual breaths.The protocol stipulates that each inhalation session lasts 15 minutes, which can be timed on the participant's own cell phone. After the inhalation is finished, the inhaler should be kept closed. To facilitate monitoring and ensure adherence to the protocol, participants will receive a weekly schedule to record completed sessions and will be encouraged to keep an aromatherapy diary to record their perceptions and feelings throughout the study, providing qualitative data that will contribute to analyzing the effect of the practice on the well-being of women undergoing fertility treatment.

COMBINATION_PRODUCTSynthetic lavender aroma inhalation

The inhalation of synthetic lavender essence will be performed twice a day, preferably upon waking and before bedtime. Participants will be instructed to find a quiet environment, lying down or sitting, to consciously perform the inhalation. The procedure consists of opening the inhaler, positioning it approximately 1 cm from the nostrils, and beginning the inhalation through habitual breaths. The protocol stipulates that each inhalation session should last 15 minutes, and the time can be timed on the participant's cell phone. After the inhalation is finished, the inhaler should be kept closed. To facilitate monitoring and ensure adherence to the protocol, participants will receive a weekly schedule to mark completed sessions and will be encouraged to keep an aromatherapy diary to record their perceptions and feelings throughout the study, providing qualitative data that will contribute to the analysis of the practice's effect on the well-being of women undergoing fertility treatment.


Locations(1)

Department of Obstetrics and Gynecology - Federal University of Minas Gerais - Brazil

Belo Horizonte, Minas Gerais, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07480668


Related Trials